{
  "ticker": "LNU",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969907",
  "id": "02969907",
  "pages": 40,
  "price_sensitive": false,
  "date": "20250716",
  "time": "1658",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250716/pdf/06lvpcrz391w6y.pdf",
  "summary": "### **Material Information Summary \u2013 Linius Technologies Limited General Meeting (14 Aug 2025)**  \n\n#### **1. Capital Raisings**  \n- **Placement (June 2025):**  \n  - **Issued:** 350M shares at $0.001/share ($350K raised).  \n  - **Free-attaching options:** 70M options (1:5 ratio), exercise $0.002, expiry 30 Jun 2027 (subject to approval under **Resolution 2**).  \n  - **Purpose:** Fund go-to-market plan, sales expansion, working capital.  \n\n- **Convertible Notes Facility (Tranche 1 & 2):**  \n  - **Tranche 1 (issued):** $350K (350K notes) at $1.00 face value, 20% p.a. interest, convertible at $0.001/share. Max dilution: ~7.4% (**Resolution 3**).  \n  - **Tranche 2 (proposed):** Up to $2.65M (2.65M notes), including:  \n    - $1.58M to non-related parties (**Resolution 4**).  \n    - $585K to related parties (directors Bongiorno, Jones, Rinarelli; **Resolutions 5\u20137**).  \n    - $480K to directors in lieu of cash remuneration (**Resolutions 8\u201311**).  \n\n---  \n#### **2. Director Remuneration & Incentives**  \n- **Convertible Notes in Lieu of Cash (Resolutions 8\u201311):**  \n  - **Total:** 480,752 notes issued (face value $1.00) to directors, converting at $0.001/share. Max dilution: ~11.03%.  \n  - **Interest:** 20% p.a. (capitalized).  \n\n- **Zero-Exercise Price Options (ZEPOs) (Resolutions 12\u201315):**  \n  - **45M ZEPOs per director** (Bongiorno, McNeill, Demetriou, Jones).  \n  - **Vesting:** Tied to share price milestones ($0.005, $0.01, $0.015 VWAP).  \n  - **Max dilution:** ~2.69%.  \n\n---  \n#### **3. Key Dates & Voting Exclusions**  \n- **Meeting:** 14 Aug 2025, 10:00 AM AEST (virtual).  \n- **Voting Exclusions:** Votes from related parties (directors/note recipients) excluded for Resolutions 1\u201315 unless voted as directed proxies.  \n\n---  \n#### **4. Dilution Impact**  \n- **Placement + Tranche 1 Notes:** ~7.4% dilution (if fully converted).  \n- **Tranche 2 Notes + ZEPOs:** Potential **13.72% aggregate dilution**.  \n\n---  \n#### **Critical Points for Traders**  \n- **Approval Likelihood:** Resolutions 1\u20134 (capital raises) likely pass; Resolutions 5\u201315 (related-party) face higher scrutiny.  \n- **Liquidity Risk:** High dilution (~21% total) if all convertible instruments exercise.  \n- **Price Sensitivity:** Low current price ($0.001) increases conversion risk; ZEPOs create sell pressure if milestones met.  \n\n**Conclusion:** Focus on passage of capital-related resolutions (1\u20134) and dilution risks. Monitor director remuneration approvals (8\u201315) for governance concerns.  \n\n*(No material operational/financial data provided in announcement.)*",
  "usage": {
    "prompt_tokens": 31108,
    "completion_tokens": 752,
    "total_tokens": 31860,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-16T08:29:14.412718"
}